We are proud to announce that our CEO, Chris Kirton, PhD, will be speaking at the upcoming National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) NAMs Network Symposium on Thursday, 1 May 2025, in London.
🗓️ Talk Title: iPSC-derived models of DILI: Challenges to acceptance
🕚Time: 10:45 – 11:00 AM BST
📍Location: London
Chris will delve into the application of our highly characterized and mature iPSC-derived hepatocyte models— Ulti-HEP, in assessing drug-induced liver injury (DILI), as well as the challenges of using Ulti-HEP to replace animals in both efficacy and toxicity testing.
Join us at the symposium to explore how our cutting-edge technologies are shaping the future of drug safety assessment and contributing to the reduction of animal testing in line with the 3Rs principles.
